News

Pharmaceutical Technology on MSN1d
BeOne Medicines’ BTK degrader gains EMA PRIME designation
The designation was based on the therapy’s novel mechanism and data showing its anti-tumour activity in B-cell malignancies.
Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
Medscape3d
EMA Reverses Previous Refusal of Kisunla for Alzheimer's
Kisunla’s active substance is donanemab, a monoclonal antibody that targets and clears amyloid-beta plaques in the brain, a ...
Pharmaceutical Technology on MSN5d
Gilead wins positive European approval opinion for twice-yearly HIV injection
"Gilead wins positive European approval opinion for twice-yearly HIV injection" was originally created and published by ...
EU regulator green lights an injectable HIV drug that could help stop transmission
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...
DPA International on MSN8d
EMA recommends approval of additional Alzheimer's treatment
The European Medicines Agency (EMA) cleared the way for the use of another drug to treat Alzheimer's disease on Friday.
Medscape3d
EMA Says No to Knee Cartilage Repair Therapy Jelrix
The European drug authority recommends refusal of marketing authorization due to evidence gaps in quality and efficacy.
STAT8d
European regulators endorse Lilly’s Alzheimer’s treatment for certain patients
European regulators said that Eli Lilly’s Alzheimer’s treatment Kisunla should be approved for select patients.
EU regulator backs Eli Lilly's Alzheimer's drug after initial rejection
Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...